524 related articles for article (PubMed ID: 18442402)
1. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.
Riker AI; Enkemann SA; Fodstad O; Liu S; Ren S; Morris C; Xi Y; Howell P; Metge B; Samant RS; Shevde LA; Li W; Eschrich S; Daud A; Ju J; Matta J
BMC Med Genomics; 2008 Apr; 1():13. PubMed ID: 18442402
[TBL] [Abstract][Full Text] [Related]
2. Integrative genome comparison of primary and metastatic melanomas.
Kabbarah O; Nogueira C; Feng B; Nazarian RM; Bosenberg M; Wu M; Scott KL; Kwong LN; Xiao Y; Cordon-Cardo C; Granter SR; Ramaswamy S; Golub T; Duncan LM; Wagner SN; Brennan C; Chin L
PLoS One; 2010 May; 5(5):e10770. PubMed ID: 20520718
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of glyceraldehyde-3-phosphate dehydrogenase expression during tumor progression of human cutaneous melanoma.
Ramos D; Pellín-Carcelén A; Agustí J; Murgui A; Jordá E; Pellín A; Monteagudo C
Anticancer Res; 2015 Jan; 35(1):439-44. PubMed ID: 25550585
[TBL] [Abstract][Full Text] [Related]
5. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease.
Chen PW; Murray TG; Uno T; Salgaller ML; Reddy R; Ksander BR
Clin Exp Metastasis; 1997 Sep; 15(5):509-18. PubMed ID: 9247253
[TBL] [Abstract][Full Text] [Related]
6. Increased HOX C13 expression in metastatic melanoma progression.
Cantile M; Scognamiglio G; Anniciello A; Farina M; Gentilcore G; Santonastaso C; Fulciniti F; Cillo C; Franco R; Ascierto PA; Botti G
J Transl Med; 2012 May; 10():91. PubMed ID: 22583695
[TBL] [Abstract][Full Text] [Related]
7. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.
Wang LX; Li Y; Chen GZ
PLoS One; 2018; 13(1):e0190447. PubMed ID: 29377892
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between B16 melanoma cells and B-1 lymphocytes induces global changes in tumor cell gene expression.
Xander P; Brito RR; Pérez EC; Pozzibon JM; de Souza CF; Pellegrino R; Bernardo V; Jasiulionis MG; Mariano M; Lopes JD
Immunobiology; 2013 Oct; 218(10):1293-303. PubMed ID: 23731774
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
10. SOX5 is involved in balanced MITF regulation in human melanoma cells.
Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
12. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of sentinel lymph node biopsy in melanomas of different Breslow's thickness.
Seyed Jafari SM; Jäckle P; Michel A; Angermeier S; Hunger R; Shafighi M
Swiss Med Wkly; 2016; 146():w14358. PubMed ID: 27684508
[TBL] [Abstract][Full Text] [Related]
14. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.
Jensen EH; Lewis JM; McLoughlin JM; Alvarado MD; Daud A; Messina J; Enkemann S; Yeatman TJ; Sondak VK; Riker AI
Ann Surg Oncol; 2007 Apr; 14(4):1416-23. PubMed ID: 17195911
[TBL] [Abstract][Full Text] [Related]
16. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.
Jaeger J; Koczan D; Thiesen HJ; Ibrahim SM; Gross G; Spang R; Kunz M
Clin Cancer Res; 2007 Feb; 13(3):806-15. PubMed ID: 17289871
[TBL] [Abstract][Full Text] [Related]
17. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
[TBL] [Abstract][Full Text] [Related]
18. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.
Thies A; Moll I; Berger J; Wagener C; Brümmer J; Schulze HJ; Brunner G; Schumacher U
J Clin Oncol; 2002 May; 20(10):2530-6. PubMed ID: 12011132
[TBL] [Abstract][Full Text] [Related]
19. Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets.
Sousa JF; Espreafico EM
BMC Cancer; 2008 Jan; 8():19. PubMed ID: 18211678
[TBL] [Abstract][Full Text] [Related]
20. The Molecular Evolution of Melanoma Distant Metastases.
Bezrookove V; Kianian S; McGeever L; Jones R; Caressi C; Nosrati M; Kim KB; Leong SP; Miller JR; Desprez PY; Kashani-Sabet M
J Invest Dermatol; 2024 Apr; ():. PubMed ID: 38582370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
